iTeos Therapeutics Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 51-100 Employees

iTeos Therapeutics revenue & valuation

Annual revenue	$35,000,000
Revenue per employee	$350,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$112,000,000
Total funding	$245,000,000

Key Contacts at iTeos Therapeutics

Prakash Patel

Director, Global Head Of Regulatory Operations

Arpit Chokshi

Director Clinical Operations

Cédric Daems

Head Of Talent Acquisition & Hr Business Partner Pre-Clinical Director

Monica Glass

Associate Director, Global Product & Portfolio Strategy

Pratheep Madasamy

Sr. Director, Head Of Global Product & Portfolio Strategy

Madhu Mawal-Dewan

Senior Director And Head Medical Writing At Iteos Therapeutics

Tim Debotze

Senior Director, Head Of Financial Planning And Analysis

Olivier De Henau

Medical Director

Gilles Castaigne

Director, Development Operations

Griet Boogaerts

Drug Development Program Management, Director

Company overview

Headquarters	139 Main Street, Cambridge, Massachusetts 02142, US
Phone number	+13271919934
Website	iteostherapeutics.com
NAICS	541714
SIC	283
Keywords	Drug Discovery, Immunotherapy, Small Molecule Immunomodulators
Founded	2011
Employees	51-100
Socials

iTeos Therapeutics Email Formats

iTeos Therapeutics uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@iteostherapeutics.com), used 60.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@iteostherapeutics.com	60.7%
{first name}.{last name}	john.doe@iteostherapeutics.com	37.1%
{first initial}.{second initial}{last name}	j.odoe@iteostherapeutics.com	1.1%
{first name}{last name}	johndoe@iteostherapeutics.com	1.1%

About iTeos Therapeutics

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT/CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Director

Employees by Department

iTeos Therapeutics has 54 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore iTeos Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-05-01	5	$125,000,000
2024-06-10	14	$120,000,000

Funding Insights

$245,000,000

Total funding amount

$120,000,000

Most recent funding amount

Number of funding rounds

iTeos Therapeutics Tech Stack

Discover the technologies and tools that power iTeos Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Cloudflare Bot Management

Security

Microsoft 365

Cloudflare

CDN

Twitter Emoji

Font scripts

Genesis theme

WordPress themes

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Frequently asked questions

iTeos Therapeutics is located in Cambridge, Massachusetts, US.

You can reach iTeos Therapeutics at +13271919934.

iTeos Therapeutics generates an estimated annual revenue of $35,000,000. This revenue figure reflects the company's market position and business performance in its industry.

iTeos Therapeutics has an estimated valuation of $112,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

iTeos Therapeutics was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.

iTeos Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

iTeos Therapeutics has raised a total of $245,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.